{"id":8968,"date":"2021-12-17T03:41:09","date_gmt":"2021-12-17T08:41:09","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/puya-supply-erstklassiges-semaglutid-cas-910463-68-2-verwendung-zur-behandlung-von-diabetes-typ-2\/"},"modified":"2021-12-17T03:41:09","modified_gmt":"2021-12-17T08:41:09","slug":"puya-supply-erstklassiges-semaglutid-cas-910463-68-2-verwendung-zur-behandlung-von-diabetes-typ-2","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/de\/product\/puya-supply-erstklassiges-semaglutid-cas-910463-68-2-verwendung-zur-behandlung-von-diabetes-typ-2\/","title":{"rendered":"Puya Supply Erstklassiges Semaglutid Cas 910463-68-2 Verwendung zur Behandlung von Diabetes Typ 2"},"content":{"rendered":"

Puya Supply Erstklassiges Semaglutid Cas 910463-68-2 Verwendung zur Behandlung von Diabetes Typ 2<\/strong><\/h2>\n

Produktname: Sermaglutid
\nSynonyme: Sermaglutide;Semaglutide fandachem;Semaglutide Verunreinigung;Sermaglutid USP\/EP\/BP;Semaglutid;Sermaglutid CAS 910463 68 2
\nCAS: 910463-68-2
\nMF: C187H291N45O59
\nMW: 4113.57754
\nEINECS: 203-405-2
\nProduktkategorien: GLP;PP;APIs;API
\nMol Datei: 910463-68-2.mol
\nPackungsgr\u00f6\u00dfe 1g\/Flasche , 10g\/Flasche,50g\/Flasche oder auf Kundenwunsch<\/p>\n

Semaglutid ist ein GLP-1 (Glucagon-like peptide-1) Analoga der neuen Generation. Semaglutid ist eine langwirksame Darreichungsform basierend auf der Grundstruktur von Liraglutid, die bei der Behandlung von Typ-2-Diabetes mellitus wirksamer ist. Im Vergleich zu Lilarlutid hat Somalutid eine l\u00e4ngere aliphobe Kette und eine erh\u00f6hte Hydrophobie, aber Somalutid ist mit einer kurzen PEG-Kette modifiziert und seine Hydrophilie ist stark erh\u00f6ht. Die PEG-Modifikation kann nicht nur fest an Albumin binden, sondern auch das DPP-4 enzymatisch \u00fcberdecken Hydrolysestelle, sondern reduzieren auch die renale Ausscheidung, verl\u00e4ngern die biologische Halbwertszeit und erzielen den Effekt einer langen Zirkulation.<\/p>\n

Funktion und Anwendung<\/strong>
\nSemaglutid (USAN; Handelsname Ozempic) ist ein Arzneimittel in der Entwicklung von einem d\u00e4nischen Unternehmen Novo Nordisk zur Behandlung von Typ-2-Diabetes. Es wird unter dem Namen Ozempic vertrieben. Als Glucagon-\u00e4hnlicher Peptid-1-Rezeptor-Agonist senkt es den Blutzuckerspiegel, indem es die Insulinproduktion erh\u00f6ht. Es wurde 2012 von einem Forscherteam von Novo Nordisk als l\u00e4nger wirkende Alternative zu Liraglutid entdeckt. Klinische Studien wurden 2015 begonnen und Phase 3 wurde 2016 abgeschlossen. Die FDA-Zulassung wurde im Dezember 2016 beantragt und im Oktober 2017 stimmte das FDA-Beratungskomitee mit 16:0 daf\u00fcr. Es kann sowohl als Injektions- als auch als orales Medikament verwendet werden.
\nForscher der University of Leeds berichteten 2017, dass es auch zur Behandlung von Fettleibigkeit eingesetzt werden kann. Es reduziert Hunger, Hei\u00dfhunger und K\u00f6rperfett.<\/p>\n","protected":false},"excerpt":{"rendered":"

Produktname: Sermaglutide
\nCAS: 910463-68-2
\nMF: C187H291N45O59
\nMW: 4113.57754
\nEINECS: 203-405-2
\nProduktkategorien: GLP;PP;APIs;API< &>Mol-Datei: 910463-68-2.mol<\/p>\n","protected":false},"featured_media":2102,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[343],"product_tag":[780,758],"class_list":{"0":"post-8968","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-diabetes-peptid","7":"product_tag-cas-910463-68-2-de","8":"product_tag-semaglutide-de","9":"desktop-align-left","10":"tablet-align-left","11":"mobile-align-left","13":"first","14":"instock","15":"shipping-taxable","16":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product\/8968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/comments?post=8968"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media\/2102"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/media?parent=8968"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_brand?post=8968"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_cat?post=8968"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/de\/wp-json\/wp\/v2\/product_tag?post=8968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}